Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Sarcoma, Novel Targeted Agents

William Tap

MD

🏢Memorial Sloan Kettering Cancer Center🌐USA

Chief, Sarcoma Medical Oncology

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

William Tap at MSK leads one of the world's premier sarcoma programs. He was principal investigator for olaratumab trials in soft tissue sarcoma and has led development of CDK4/6 inhibitors and MDM2 inhibitors for liposarcoma. His research on sarcoma subtypes, novel biologic agents, and adaptive trial designs has advanced the evidence base for an array of rare sarcoma diagnoses.

Share:

🧪Research Fields 研究领域

sarcoma
olaratumab
CDK4/6 inhibitors liposarcoma
PDGFRA sarcoma
synovial sarcoma

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-02-01 | All information from publicly available academic sources

关注 William Tap 的研究动态

Follow William Tap's research updates

留下邮箱,当我们发布与 William Tap(Memorial Sloan Kettering Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment